Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. COSMOS Pharmaceutical Corporation
  6. Summary
    3349   JP3298400007

COSMOS PHARMACEUTICAL CORPORATION

(3349)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
10/14/2021 10/15/2021 10/18/2021 10/19/2021 10/20/2021 Date
17920 18320 17660 18060 17960 Last
145800 119000 160000 112800 80800 Volume
+0.22% +2.23% -3.60% +2.27% -0.55% Change
Estimated financial data (e)
Sales 2022 761 B 6 676 M 6 676 M
Net income 2022 25 234 M 221 M 221 M
Net cash position 2022 59 026 M 518 M 518 M
P/E ratio 2022 28,2x
Yield 2022 0,41%
Sales 2023 819 B 7 187 M 7 187 M
Net income 2023 27 317 M 240 M 240 M
Net cash position 2023 67 306 M 591 M 591 M
P/E ratio 2023 26,0x
Yield 2023 0,44%
Capitalization 711 B 6 226 M 6 240 M
EV / Sales 2022 0,86x
EV / Sales 2023 0,79x
Nbr of Employees -
Free-Float 47,3%
More Financials
Company
COSMOS Pharmaceutical Corporation is a company primarily engaged in the operation of drug stores. The Company offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous... 
More about the company
Ratings of COSMOS Pharmaceutical Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about COSMOS PHARMACEUTICAL CORPORATION
07/13Topix closes at near one-month high as investors await earnings
RE
05/28COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for final dividend
FA
2020COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for interim dividend
FA
2020COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for final dividend
FA
2020COSMOS PHARMACEUTICAL CORPORATION : SPLIT: 2 of 1
FA
2019COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2019COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
2018COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2018COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
2018Hidefuji Co., Ltd. acquired 5.25% stake in COSMOS Pharmaceutical Corporation from Masat..
CI
2017COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2017COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
2016COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2016COSMOS PHARMACEUTICAL CORPORATION(TS : 3349) added to S&P Japan 500
CI
2016COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
More news
News in other languages on COSMOS PHARMACEUTICAL CORPORATION
07/13Borsa Tokyo, Topix a massimi di quasi un mese, mercato attende trimestrali
2019AVIS D'ANALYSTES DU JOUR : Capgemini, Total, Peugeot, Michelin, Maisons du Monde, Richemon..
2019Trump et Powell dans le même bas-taux ?
2019AVIS D'ANALYSTES DU JOUR : Airbus, Groupe ADP, Tarkett, Solutions 30, Boskalis, Polyphor, ..
2018AVIS D'ANALYSTES DU JOUR : Airbus, Altice, Kering, Nestlé, Ingenico...
More news
Chart COSMOS PHARMACEUTICAL CORPORATION
Duration : Period :
COSMOS Pharmaceutical Corporation Technical Analysis Chart | 3349 | JP3298400007 | MarketScreener
Technical analysis trends COSMOS PHARMACEUTICAL CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 17 960,00 JPY
Average target price 18 761,54 JPY
Spread / Average Target 4,46%
EPS Revisions
Managers and Directors
Hideaki Yokoyama President & Representative Director
Masateru Uno Chairman
Masahiro Iwashita Executive Officer & Manager-Information Systems
Masao Ueda Independent Outside Director
Futoshi Shibata Director & Manager-Corporate Planning
Sector and Competitors